December 18, 2018 Bayer announces WHO pre-qualification for Fludora™ Fusion to combat malariaRead more
December 14, 2018 Bayer and the S M Sehgal Foundation announce a new project:Supporting livelihoods and nutrition of smallholder farmers in IndiaRead more
December 7, 2018 First Anniversary of Bayer’s Transparency InitiativeBayer committed to transparency: Posts more than 300 glyphosate safety study summaries onlineRead more
December 5, 2018 Capital Markets Day 2018Bayer to drive value creation as company pursues ambitious growth targets through 2022Read more
December 3, 2018 Chronic Thromboembolic Pulmonary Hypertension (CTEPH)FDA grants breakthrough device designation to artificial intelligence software for CTEPH pattern recognition from Bayer and MSDRead more
PRESS KIT November 29, 2018 Group to take comprehensive range of portfolio, efficiency and structural measuresBayer to strengthen core life science businesses while significantly enhancing productivity and profitabilityRead more
November 29, 2018 Group to take comprehensive range of portfolio, efficiency and structural measuresBayer to strengthen core life science businesses while significantly enhancing productivity and profitabilityRead more
SPECIALIZED PRESS November 27, 2018 Not intended for U.S. and UK MediaBayer receives EU approval for its hemophilia A treatment Jivi®Read more
SPECIALIZED PRESS November 27, 2018 Not intended for U.S. and UK MediaU.S. FDA approves Larotrectinib, the first TRK inhibitor, for patients with advanced solid tumors harboring an NTRK gene fusionRead more
.jpg)
